An Observational Study to Determine the Real-Life Effectiveness of MP-AzeFlu ® in Austrian Patients with Persistent Allergic Rhinitis.

Katharina MarthAndreas RennerGeorg LangmayrWolfgang PohlDuc Tung NguyenHans Christian Kuhl

Published in: Drugs - real world outcomes (2024)

Many patients in Austria live with uncontrolled persistent AR despite treatment. MP-AzeFlu provides effective and rapid control of persistent AR in a real-world Austrian setting.

Keyphrases

allergic rhinitis
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
randomized controlled trial
systematic review
peritoneal dialysis
quantum dots